| Editor's choice–management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS) V Riambau, D Böckler, J Brunkwall, P Cao, R Chiesa, G Coppi, M Czerny, ... European Journal of Vascular and Endovascular Surgery 53 (1), 4-52, 2017 | 987 | 2017 |
| Autologous transplantation and maintenance therapy in multiple myeloma A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ... New England Journal of Medicine 371 (10), 895-905, 2014 | 907 | 2014 |
| Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015 | 782 | 2015 |
| Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial PP Terragni, M Antonelli, R Fumagalli, C Faggiano, M Berardino, ... Jama 303 (15), 1483-1489, 2010 | 652 | 2010 |
| Efficacy and safety of once-weekly bortezomib in multiple myeloma patients S Bringhen, A Larocca, D Rossi, M Cavalli, M Genuardi, R Ria, S Gentili, ... Blood, The Journal of the American Society of Hematology 116 (23), 4745-4753, 2010 | 499 | 2010 |
| Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial A Palumbo, M Cavo, S Bringhen, E Zamagni, A Romano, F Patriarca, ... Journal of Clinical Oncology 29 (8), 986-993, 2011 | 395 | 2011 |
| Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a … F Gay, S Oliva, MT Petrucci, C Conticello, L Catalano, P Corradini, ... The lancet oncology 16 (16), 1617-1629, 2015 | 364 | 2015 |
| Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide A Larocca, F Cavallo, S Bringhen, F Di Raimondo, A Falanga, ... Blood, The Journal of the American Society of Hematology 119 (4), 933-939, 2012 | 339 | 2012 |
| Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data A Palumbo, S Bringhen, SK Kumar, G Lupparelli, S Usmani, A Waage, ... The lancet oncology 15 (3), 333-342, 2014 | 336 | 2014 |
| Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials S Bringhen, MV Mateos, S Zweegman, A Larocca, AP Falcone, A Oriol, ... Haematologica 98 (6), 980, 2013 | 259 | 2013 |
| Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials I Cioffi, A Evangelista, V Ponzo, G Ciccone, L Soldati, L Santarpia, ... Journal of translational medicine 16, 1-15, 2018 | 209 | 2018 |
| Extracorporeal CO2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control L Del Sorbo, L Pisani, C Filippini, V Fanelli, L Fasano, P Terragni, ... Critical care medicine 43 (1), 120-127, 2015 | 192 | 2015 |
| Correlation between NK function and response to trastuzumab in metastatic breast cancer patients A Beano, E Signorino, A Evangelista, D Brusa, M Mistrangelo, ... Journal of translational medicine 6, 1-10, 2008 | 182 | 2008 |
| Deep Impact of Ultrasound in the Intensive Care Unit: The “ICU-sound” Protocol E Manno, M Navarra, L Faccio, M Motevallian, L Bertolaccini, A Mfochivè, ... Anesthesiology 117 (4), 801-809, 2012 | 175 | 2012 |
| Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database E Ruffini, F Detterbeck, D Van Raemdonck, G Rocco, P Thomas, W Weder, ... European Journal of Cardio-Thoracic Surgery 46 (3), 361-368, 2014 | 169 | 2014 |
| Effects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysis M Pellegrini, I Cioffi, A Evangelista, V Ponzo, I Goitre, G Ciccone, E Ghigo, ... Reviews in endocrine and metabolic disorders 21, 17-33, 2020 | 158 | 2020 |
| Interim positron emission tomography response-adapted therapy in advanced-stage Hodgkin lymphoma: final results of the phase II part of the HD0801 study PL Zinzani, A Broccoli, DM Gioia, A Castagnoli, G Ciccone, A Evangelista, ... Journal of clinical oncology 34 (12), 1376-1385, 2016 | 156 | 2016 |
| Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final … A Chiappella, M Martelli, E Angelucci, E Brusamolino, A Evangelista, ... The Lancet Oncology 18 (8), 1076-1088, 2017 | 145 | 2017 |
| Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi C Visco, A Chiappella, L Nassi, C Patti, S Ferrero, D Barbero, ... The Lancet Haematology 4 (1), e15-e23, 2017 | 144 | 2017 |
| Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial S Bo, V Ponzo, G Ciccone, A Evangelista, F Saba, I Goitre, M Procopio, ... Pharmacological research 111, 896-905, 2016 | 138 | 2016 |
